Skip to content

Effectiveness of Hematoma block in acute pain management and closed reduction of fractures in children presenting to DHQ Kohat: An exploratory RCT

Effectiveness of Hematoma block in acute pain management and closed reduction of fractures in children presenting to DHQ Kohat: An exploratory RCT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12620001138976
Enrollment
121
Registered
2020-11-02
Start date
2019-11-12
Completion date
2020-11-30
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Hematoma block and Intravenous analgesia are both simple options, as none of these techniques require expertise or special equipments . Hematoma block is not compared with IV analgesia in children with fractures of lower segment of limbs before. In view of the above, a study is to be undertaken to evaluate the effects of hematoma block and Intravenous analgesic for closed reduction of fractures and for immediate pain relief in individuals.

Interventions

Hematoma block and intravenous analgesia are the two interventions which will be administered by the Surgeon. Patients will be randomized to one of the groups. Each patient will only recieve one intervention. The intervention will be administered immediately before the fracture reduction. Hematoma block: Fracture hematoma will be injected with 2% lignocaine in a dose of 0.5 ml/kg. Intravenous analgesia: Injection Ketorolac (Toradol) will be injected in the Cubital vein of the contralateral l

Hematoma block and intravenous analgesia are the two interventions which will be administered by the Surgeon. Patients will be randomized to one of the groups. Each patient will only recieve one intervention. The intervention will be administered immediately before the fracture reduction. Hematoma block: Fracture hematoma will be injected with 2% lignocaine in a dose of 0.5 ml/kg. Intravenous analgesia: Injection Ketorolac (Toradol) will be injected in the Cubital vein of the contralateral limb in a dose of 0.2 ml/kg.

Sponsors

Khalid Rehman
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
7 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

Age between 7-14 years. Simple/closed fracture pattern. Fractures of the forearm or shin bone. Fracture duration less than 24 hours. Parents Consent. Childs Assent.

Exclusion criteria

Children with any co morbid disease, intra-articular, and epiphyseal fractures. Un-displaced forearm and shin bone fractures which do not require manipulation. Patients with multiple fractures.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026